0
Pulmonary Vascular Disease |

A Case of Recurrent Massive Pulmonary Embolism in Klippel-Trenaunay-Weber Syndrome Treated With Thrombolytics

Abhay Vakil, MD; Khalid Sherani, MD; Viral Patel, MBBS; Kelly Cervellione, PhD; Mohammed Babury, MD
Author and Funding Information

Jamaica Hospital Medical Center, Jamaica, NY


Chest. 2014;145(3_MeetingAbstracts):505A. doi:10.1378/chest.1826532
Text Size: A A A
Published online

Abstract

SESSION TITLE: Pulmonary Vascular Case Report Posters

SESSION TYPE: Case Report Poster

PRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PM

INTRODUCTION: Klippel-Trenaunay-Weber syndrome (KTWS) is a rare congenital condition characterized by extensive venous malformations and soft tissue and bone hypertrophy. KTWS predisposes to hypercoagulable states, including venous thromboembolism (VTE) and pulmonary embolism (PE). The incidence of PE ranges from 14-22 %; however, recurrent massive PE is unusual. We report the case of an adult female with KTWS who developed recurrent massive PE and was successfully treated with thrombolytic therapy.

CASE PRESENTATION: A 36-year-old female with history of KTWS and previous massive PE one year prior, noncompliant with anticoagulation therapy, presented with sudden onset pleuritic chest pain, dyspnea and diaphoresis. At presentation blood pressure was 80/64mmHg, pulse was 150bpm, respiratory rate was 22 and SpO2 on room air was 87%. Physical examination revealed significant swelling of the left leg with prominent venous irregularities. CT pulmonary angiogram revealed filling defect in both main pulmonary arteries with no pulmonary infarcts. 2D echocardiogram showed increased right ventricular size and bowing of the septum into the left ventricle with elevated PA pressure (64 mmHg). Thrombolytic therapy was administered, hemodynamic improvement was noted over the next 24 hours. Repeat 2D echocardiogram showed resolution of right ventricular overload. The patient was advised to continue lifelong anticoagulation therapy.

DISCUSSION: The common pulmonary manifestations of KTWS include thromboembolic phenomena, pulmonary venous varicosities, pulmonary lymphatic obstruction and cavernous hemangiomas of the pleura. Missed diagnosis of these KTWS associated complications can potentially be life threatening. Due to the rarity of this disease, there are no recommended guidelines for the management of thromboembolic phenomena. However, aggressive therapeutic anticoagulation and early placement of IVC filter have been suggested.

CONCLUSIONS: This rare congenital condition and associated complications can at times be difficult to manage. The management of prophylaxis for PE recurrence is an area that needs special attention.

Reference #1: Adriane Gianlupi, MD; Richart W. Harper, MD; Denis M. Dwyre, MD; Gregory P. Marelich, MD, FCCP, "Recurrent Pulmonary Embolism Associated With Klippel-Trenaunay-Weber Syndrome" Chest. 1999;115(4):1199-1201. doi:10.1378/chest.115.4.1199

Reference #2: Erin E. Huiras, MD, Cheryl J. Barnes, MD, Lawrence F. Eichenfield, MD, Andrew N. Pelech, MD, Beth A. Drolet, MD, "Pulmonary Thromboembolism Associated With Klippel-Trenaunay Syndrome" Published online September 15, 2005 PEDIATRICS Vol. 116 No. 4 October 1, 2005 pp. e596 -e600

Reference #3: Mikula, N, Gupta, SM, Miller, M, et al Klippel-Trenaunay-Weber syndrome with recurrent pulmonary embolism.Clin Nucl Med1991;16,253-255

DISCLOSURE: The following authors have nothing to disclose: Abhay Vakil, Khalid Sherani, Viral Patel, Kelly Cervellione, Mohammed Babury

No Product/Research Disclosure Information


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
Guidelines
Guidelines on use of vena cava filters.
British Committee for Standards in Haematology | 9/25/2009
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543